Key result
Hepatitis B and D infections show no association with cardiovascular disease.
Why the study?
Viral infections such as hepatitis B and D may influence heart failure development, but their association with cardiovascular diseases alongside metabolic syndrome is unclear.
Are Hepatitis B and D infections and metabolic syndrome associated with cardiovascular diseases?
Cross-Sectional (n=239)
No
Are Hepatitis B and D infections and metabolic syndrome associated with cardiovascular diseases?
Answers are grounded in this paper and cite their sources.
This study demonstrates no association between HBV/HDV infection and cardiovascular diseases, but reaffirms the significant role of metabolic syndrome and hyperglycemia in CVD.
Background: Viral infections may play a significant role in the development of heart failure, especially in people with related cardiac conditions such as myocarditis. Hepatitis B and D viruses (HBV-HDV) are potentially fatal liver infections. This study examined the influence of metabolic syndrome and its associated disorders. Materials & Methods: This cross-sectional study investigated hepatitis D antibody and hepatitis B surface antigen (HBsAg) in 239 people aged 35 to 65 years in Mashhad, Khorasan Razavi Province, Iran in 2018-2019. There were two study groups: those with cardiovascular diseases (CVD) and healthy individuals. Serum samples of all subjects in both groups were examined using enzyme-linked immunosorbent assay (ELISA). Findings: HDV infection was detected in none of the study groups. Only one patient (0.8%) in the case group tested positive for HBsAg. The average LDL (low-density lipoprotein) (p= .8) and cholesterol (p= .3) levels in terms of lipid profiles were similar in both groups. Although the mean high-density lipoprotein (HDL) level in the patient group was lower, the mean triglyceride level in this group was higher than in the control group. Fasting blood sugar (FBS) (p= .009) and aspartate aminotransferase (AST) levels were significantly higher in CVD patients, while 59.3% of them exhibited metabolic syndrome. Conclusion: This study results demonstrate no connection between HBV/HDV infection and cardiovascular diseases. The findings confirm that metabolic syndrome and hyperglycemia are underlying factors in cardiovascular diseases. Changes in HDL and triglyceride levels could impact cardiovascular diseases more than other lipids.
No takes yet. Share an insight, caveat, or question.
Dehghani et al. (2024) conducted a cross-sectional in Cardiovascular diseases (n=239). Hepatitis B and D infection vs. Healthy individuals was evaluated on HBsAg positivity. Hepatitis B and D infections showed no association with cardiovascular diseases, with only 0.8% of CVD patients testing positive for HBsAg and 0% for HDV.
Synapse has enriched 10 related papers. Consider them for comparative context: